354 related articles for article (PubMed ID: 10741725)
21. Slow-down of age-dependent telomere shortening is executed in human skin keratinocytes by hormesis-like-effects of trace hydrogen peroxide or by anti-oxidative effects of pro-vitamin C in common concurrently with reduction of intracellular oxidative stress.
Yokoo S; Furumoto K; Hiyama E; Miwa N
J Cell Biochem; 2004 Oct; 93(3):588-97. PubMed ID: 15378602
[TBL] [Abstract][Full Text] [Related]
22. Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells.
Saretzki G; Ludwig A; von Zglinicki T; Runnebaum IB
Cancer Gene Ther; 2001 Oct; 8(10):827-34. PubMed ID: 11687906
[TBL] [Abstract][Full Text] [Related]
23. Senescence and telomere shortening induced by novel potent G-quadruplex interactive agents, quindoline derivatives, in human cancer cell lines.
Zhou JM; Zhu XF; Lu YJ; Deng R; Huang ZS; Mei YP; Wang Y; Huang WL; Liu ZC; Gu LQ; Zeng YX
Oncogene; 2006 Jan; 25(4):503-11. PubMed ID: 16170347
[TBL] [Abstract][Full Text] [Related]
24. Cyclic induction of senescence with intermittent AZT treatment accelerates both apoptosis and telomere loss.
Ji HJ; Rha SY; Jeung HC; Yang SH; An SW; Chung HC
Breast Cancer Res Treat; 2005 Oct; 93(3):227-36. PubMed ID: 16132531
[TBL] [Abstract][Full Text] [Related]
25. Telomere dynamics in cells with introduced telomerase: a rapid assay for telomerase activity on telomeres.
McChesney PA; Aisner DL; Frank BC; Wright WE; Shay JW
Mol Cell Biol Res Commun; 2000 May; 3(5):312-8. PubMed ID: 10964756
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3'-azido-3'-deoxythymidine.
Melana SM; Holland JF; Pogo BG
Clin Cancer Res; 1998 Mar; 4(3):693-6. PubMed ID: 9533539
[TBL] [Abstract][Full Text] [Related]
27. Activity of a novel G-quadruplex-interactive telomerase inhibitor, telomestatin (SOT-095), against human leukemia cells: involvement of ATM-dependent DNA damage response pathways.
Tauchi T; Shin-Ya K; Sashida G; Sumi M; Nakajima A; Shimamoto T; Ohyashiki JH; Ohyashiki K
Oncogene; 2003 Aug; 22(34):5338-47. PubMed ID: 12917635
[TBL] [Abstract][Full Text] [Related]
28. Telomerase template antagonist GRN163L disrupts telomere maintenance, tumor growth, and metastasis of breast cancer.
Hochreiter AE; Xiao H; Goldblatt EM; Gryaznov SM; Miller KD; Badve S; Sledge GW; Herbert BS
Clin Cancer Res; 2006 May; 12(10):3184-92. PubMed ID: 16707619
[TBL] [Abstract][Full Text] [Related]
29. Binding of G-quadruplex-interactive agents to distinct G-quadruplexes induces different biological effects in MiaPaCa cells.
Liu W; Sun D; Hurley LH
Nucleosides Nucleotides Nucleic Acids; 2005; 24(10-12):1801-15. PubMed ID: 16438049
[TBL] [Abstract][Full Text] [Related]
30. Telomerase inhibition is a specific early event in salvicine-treated human lung adenocarcinoma A549 cells.
Liu WJ; Zhang YW; Shen Y; Jiang JF; Miao ZH; Ding J
Biochem Biophys Res Commun; 2004 Oct; 323(2):660-7. PubMed ID: 15369801
[TBL] [Abstract][Full Text] [Related]
31. Telomerase inhibition, telomere shortening, cell growth suppression and induction of apoptosis by telomestatin in childhood neuroblastoma cells.
Binz N; Shalaby T; Rivera P; Shin-ya K; Grotzer MA
Eur J Cancer; 2005 Dec; 41(18):2873-81. PubMed ID: 16253503
[TBL] [Abstract][Full Text] [Related]
32. Azidothymidine induces apoptosis and inhibits cell growth and telomerase activity of human parathyroid cancer cells in culture.
Falchetti A; Franchi A; Bordi C; Mavilia C; Masi L; Cioppi F; Recenti R; Picariello L; Marini F; Del Monte F; Ghinoi V; Martineti V; Tanini A; Brandi ML
J Bone Miner Res; 2005 Mar; 20(3):410-8. PubMed ID: 15746985
[TBL] [Abstract][Full Text] [Related]
33. Suppression of telomerase activity as an indicator of drug-induced cytotoxicity against cancer cells: in vitro studies with fresh human tumor samples.
Faraoni I; Graziani G; Turriziani M; Masci G; Mezzetti M; Testori A; Veronesi U; Bonmassar E
Lab Invest; 1999 Aug; 79(8):993-1005. PubMed ID: 10462037
[TBL] [Abstract][Full Text] [Related]
34. Adenoviral-mediated retinoblastoma 94 produces rapid telomere erosion, chromosomal crisis, and caspase-dependent apoptosis in bladder cancer and immortalized human urothelial cells but not in normal urothelial cells.
Zhang X; Multani AS; Zhou JH; Shay JW; McConkey D; Dong L; Kim CS; Rosser CJ; Pathak S; Benedict WF
Cancer Res; 2003 Feb; 63(4):760-5. PubMed ID: 12591722
[TBL] [Abstract][Full Text] [Related]
35. Progressive telomere shortening occurs in cultured rat microglia, but not astrocytes.
Flanary BE; Streit WJ
Glia; 2004 Jan; 45(1):75-88. PubMed ID: 14648548
[TBL] [Abstract][Full Text] [Related]
36. Oligonucleotide N3'-->P5' phosphoramidates as efficient telomerase inhibitors.
Herbert BS; Pongracz K; Shay JW; Gryaznov SM
Oncogene; 2002 Jan; 21(4):638-42. PubMed ID: 11850790
[TBL] [Abstract][Full Text] [Related]
37. Consequences of telomerase inhibition and combination treatments for the proliferation of cancer cells.
Chen Z; Koeneman KS; Corey DR
Cancer Res; 2003 Sep; 63(18):5917-25. PubMed ID: 14522918
[TBL] [Abstract][Full Text] [Related]
38. Antitumor activity of the antimicrobial peptide magainin II against bladder cancer cell lines.
Lehmann J; Retz M; Sidhu SS; Suttmann H; Sell M; Paulsen F; Harder J; Unteregger G; Stöckle M
Eur Urol; 2006 Jul; 50(1):141-7. PubMed ID: 16476519
[TBL] [Abstract][Full Text] [Related]
39. Telomerase vaccination has no detectable effect on SCID-repopulating and colony-forming activities in the bone marrow of cancer patients.
Danet-Desnoyers GA; Luongo JL; Bonnet DA; Domchek SM; Vonderheide RH
Exp Hematol; 2005 Nov; 33(11):1275-80. PubMed ID: 16263411
[TBL] [Abstract][Full Text] [Related]
40. Telomere dynamics and telomerase activity in in vitro immortalised human cells.
Bryan TM; Reddel RR
Eur J Cancer; 1997 Apr; 33(5):767-73. PubMed ID: 9282115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
